Lijuan Guo

Lijuan Guo

Auto-generated profile, based on publicly available information

Lijuan Guo

Department of Breast Cancer, Guangdong Provincial People's Hospital's Nanhai Hospital, Foshan, 528000, Guangdong, China

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2021 in Chinese Medical Journal
Verified
Journal Article
Open access
LJLei Jing
Lei Jing
WCWenhui Chen
Wenhui Chen
LZLi Zhao
Li Zhao
LGLijuan Guo
Lijuan Guo
CLChaoyang Liang
Chaoyang Liang
CWChen Wang
Chen Wang
Background: Acute kidney injury (AKI) is a common and serious complication following lung transplantation (LTx), and it is associated with high mortality and morbidity. This study assessed the incidence of AKI after LTx and analyzed the associated perioperative factors and clinical outcomes. Methods: This retrospective study included all adult LTx recipients at the China-Japan Friendship Hospital in Beijing between March 2017 and December 2019. The outcomes were AKI incidence, risk factors, mortality, and kidney recovery. Multivariate analysis was performed to identify independent risk factors. Survival analysis was presented using the Kaplan–Meier curves. Results: AKI occurred in 137 of the 191 patients (71.7%), with transient AKI in 43 (22.5%) and persistent AKI in 94 (49.2%). AKI stage 1 occurred in 27/191 (14.1%), stage 2 in 46/191 (24.1%), and stage 3 in 64/191 (33.5%) of the AKI patients. Renal replacement therapy (RRT) was administered to 35/191 (18.3%) of the patients. Male sex, older age, mechanical ventilation (MV), severe hypotension, septic shock, multiple organ dysfunction (MODS), prolonged extracorporeal membrane oxygenation (ECMO), reintubation, and nephrotoxic agents were associated with AKI (P < 0.050). Persistent AKI was independently associated with pre-operative pulmonary hypertension, severe hypotension, post-operative MODS, and nephrotoxic agents. Severe hypotension, septic shock, MODS, reintubation, prolonged MV, and ECMO during or after LTx were related to severe AKI (stage 3) (P < 0.050). Patients with persistent and severe AKI had a significantly longer duration of MV, longer duration in the intensive care unit (ICU), worse downstream kidney function, and reduced survival (P < 0.050). Conclusions: AKI is common after LTx, but the pathogenic mechanism of AKI is complicated, and prerenal causes are important. Persistent and severe AKI were associated with poor short- and long-term kidney function and reduced survival in LTx patients.

1 January 2023 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
XLXiao-Yi Lin
Xiao-Yi Lin
LGLijuan Guo
Lijuan Guo
XLXin Lin
Xin Lin
YWYulei Wang
Yulei Wang
GZGuochun Zhang
Guochun Zhang
Lin X, et al. J Breast Cancer. 2023 Jul;26:e30. https://doi.org/10.4048/jbc.2023.26.e30

1 October 2008 in Chinese Medical Journal
Verified
Journal Article
Open access
SYSen Yang
Sen Yang
XWXiao-Yi Wang
Xiao-Yi Wang
LGLi-Juan Guo
Li-Juan Guo
XTXiu-Fa Tang
Xiu-Fa Tang
QGQing-Hong Gao
Qing-Hong Gao
YCYu-Tang Cao
Yu-Tang Cao
Researchers have recently demonstrated that thrombospondin-1 (TSP-1) has an important function in regulating neovascularization. Whether it inhibits or accelerates neovascularization, however, is still controversial. We found few reports about the correlation between TSP-1 and vascularization in mucoepidermoid carcinoma. In this research, the distribution and expression of TSP-1 in mucoepidermoid carcinoma were investigated. We also analyzed (1) the correlation between the expression of TSP-1 and microvessel density (MVD), as an indicator of neovascularization activity, and (2) the effect of TSP-1 on neovascularization and tumor growth in the subcutaneous xenotransplanted model of mucoepidermoid carcinoma. (1) The sites and intensity of expression of TSP-1 and the MVD were analyzed in 45 cases of mucoepidermoid carcinoma after surgery by the method of streptavidin-peroxidase (SP) immunohistochemistry; and (2) recombinant human thrombospondin-1 (rhTSP-1) was injected twice a week for five consecutive weeks around the tumor in the subcutaneous xenotransplanted tumor model of mucoepidermoid carcinoma in nude mice. Each week, the tumor size was measured, in order to draw the growth curve of the xenotransplanted tumor model of mucoepidermoid carcinoma, and MVD was measured. (1) The positive expression of TSP-1 protein was 57.78% (26/45). Most positive staining for TSP-1 was found in the cytoplasm of the cancer cells, while some staining occurred in the extracellular matrix. The mean MVD in 45 cases of mucoepidermoid carcinoma was 58.17±19.77 per 100 visual fields. Tumors with a high expression of TSP-1 showed a low MVD value, and the TSP-1 immunocompetence and microvessel density showed a significant negative correlation (r s=-0.947, P <0.001). (2) The xenotransplanted tumors with the injection doses of 1.25, 0.75 and 0.25 μg/ml respectively were 36.97%, 53.36% and 73.61% of the size of the control group ((451±92), (651±113), (898±86) and (1220±157) mm3 respectively, F=53.167, P <0.001), and their weights were respectively 35.14%, 51.35% and 70.27% of the control group ((1.3±0.5), (1.9±0.5), (2.6±0.3), and (3.7±0.7) g respectively, F=62.669, P <0.001). Their MVDs were 25.00%, 45.93%, and 72.20% respectively of the control group and concentration dependent (15.43±3.45, 28.35±4.24, 44.57±3.35 and 61.73±5.43 per 100 visual fields respectively, F=54.582, P<0.001). The TSP-1 has a higher expression in mucoepidermoid carcinoma and the expression has a significant negative correlation with neovascularization. The TSP-1 inhibits neovascularization and tumor growth, and it might be a new biological therapy for treatment of patients with mucoepidermoid carcinoma.

18 May 2026 in Current Cancer Therapy Reviews
Verified
Journal Article
Closed access
PDF file
LGLijuan Guo
Lijuan Guo
YZYi Zhang
Yi Zhang
YZYicong Zhang
Yicong Zhang
XLXin Lin
Xin Lin
JLJiali Lin
Jiali Lin
YZYifang Zhang
Yifang Zhang
Introduction: Previous studies reported the relationship between telomere length (TL) and breast cancer risk, but the effect of TL on breast cancer risk, especially subtype-specific breast cancer, is still controversial. We used a bidirectional two-sample Mendelian randomization (MR) analysis to investigate the causal association between TL and breast cancer risk with pre-set individual subtype stratification. Methods: Genetic instruments for TL were obtained from genome-wide association studies (GWAS) of the UK Biobank, which included 472,174 individuals of European ancestry. Breast cancer GWAS summary statistics were obtained from Breast Cancer Association Consortium (BCAC), including 122,977 cases and 105,974 controls for overall and subtype analyses. Inverse-- variance weighted (IVW) is the main method used to estimate odds ratios (ORs) and 95% confidence intervals (CI), and alternative MR methods, including MR-Egger, weighted median, and weighted mode, are estimated. Results: Our study indicated that genetically shorter telomere length (TL) was associated with an increased risk of triple-negative breast cancer (TNBC) (IVW: OR=0.77, 95% CI=0.61-0.96, P =0.02). And a similar causal relationship was also found in BRCA1-mutated TNBC (IVW: OR=0.76, 95% CI=0.64-0.91, P =2.8E-03). Moreover, we did not find any causal effect of TNBC or BRCA1-mutated TNBC on TL, nor did any other breast cancer subtypes have an effect on TL. Discussion: These bidirectional Mendelian randomization analyses support a subtype-specific inverse causal association between genetically determined TL and the risk of TNBC, particularly in BRCA1-mutated TNBC. These findings provide MR-based population-level etiological evidence, highlighting a potential role of telomere biology in specific breast cancer subtypes and warranting further investigation into the underlying biological mechanism. Conclusion: These results highlight the potential importance of telomere biology in TNBC etiology and warrant further investigation into the underlying biological mechanisms.

12 October 2021 in Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases
Verified
Journal Article
Closed access
NYN N Yuan
N N Yuan
LGL J Guo
L J Guo
LZLi Zhao
Li Zhao
SZS Zhang
S Zhang
LJL Jing
L Jing
WCW H Chen
W H Chen
Objective: To report the risk factors, clinical characteristics and treatment courses of pulmonary mucormycosis after lung transplantation(LT). Methods: We included 3 cases with pulmonary mucormycosis after LT from March 2017 to July 2020 in the centre for lung transplantation of China-Japan Friendship Hospital. Twelve cases from Chinese and English literature from China National Knowledge Infrastructure (CNKI), China Biomedical Literature Service System and Pubmed Database from March 1980 to July 2020 were added. The risk factors, clinical characteristics and treatment courses of all cases were summarized and analyzed. Results: Pulmonary mucormycosis occurred in 1.06% (3/284) in our centre. A total of 15 cases with 12 cases from literature included 10 males and 5 females with a mean age of(47±20)years. Thirteen cases occurred after LT, and 2 cases occurred after heart-lung transplantation (HLT). Nine probable cases were diagnosed by positive isolation of the pathogen from bronchoalveolar lavage fluid or sputum. Three proven cases were diagnosed by transbronchial lung biopsy. Meanwhile, the other 3 proven cases diagnosed by CT-guided percutaneous lung biopsy, autopsy and surgical operation respectively. Ten cases (66.7%) were diagnosed with pulmonary mucormycosis within 90 days after lung transplantation. The mortality was as high as 46.67% (7/15), but if it occurred within 90 days, the mortality reached 70% (7/10). The average interval between transplantation and positive isolation of the pathogen was 112.3 (5-378) days. Conclusions: The clinical and radiographic features of pulmonary mucormycosis after LT were nonspecific. It had a high mortality, especially in those occurred within 90 days after LT. The combination of antifungal therapy and surgical resection may contribute to a better outcome of the disease.